Poole DJ - Search Results

1

Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies.

Hand PH, Robbins PF, Salgaller ML, Poole DJ, Schlom J. Hand PH, et al. Among authors: poole dj. Cancer Immunol Immunother. 1993;36(2):65-75. doi: 10.1007/BF01754404. Cancer Immunol Immunother. 1993. PMID: 8425211 Free PMC article.

2

The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines.

Arlen P, Tsang KY, Marshall JL, Chen A, Steinberg SM, Poole D, Hand PH, Schlom J, Hamilton JM. Arlen P, et al. Cancer Immunol Immunother. 2000 Dec;49(10):517-29. doi: 10.1007/s002620000145. Cancer Immunol Immunother. 2000. PMID: 11129322 Free PMC article.

3

Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.

Kuroki M, Fernsten PD, Wunderlich D, Colcher D, Simpson JF, Poole DJ, Schlom J. Kuroki M, et al. Among authors: poole dj. Cancer Res. 1990 Aug 15;50(16):4872-9. Cancer Res. 1990. PMID: 1696162

4

Baculovirus recombinants expressing the human carcinoembryonic antigen gene.

Salgaller ML, Bei R, Schlom J, Poole DJ, Robbins PF. Salgaller ML, et al. Among authors: poole dj. Cancer Res. 1993 May 1;53(9):2154-61. Cancer Res. 1993. PMID: 8481918

5

A CDR-grafted (humanized) domain-deleted antitumor antibody.

Slavin-Chiorini DC, Kashmiri SV, Lee HS, Milenic DE, Poole DJ, Bernon E, Schlom J, Hand PH. Slavin-Chiorini DC, et al. Among authors: poole dj. Cancer Biother Radiopharm. 1997 Oct;12(5):305-16. doi: 10.1089/cbr.1997.12.305. Cancer Biother Radiopharm. 1997. PMID: 10851481

6

Vaccine therapy of established tumors in the absence of autoimmunity.

Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J. Hodge JW, et al. Among authors: poole dj. Clin Cancer Res. 2003 May;9(5):1837-49. Clin Cancer Res. 2003. PMID: 12738742

7

Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.

Hodge JW, Poole DJ, Aarts WM, Gómez Yafal A, Gritz L, Schlom J. Hodge JW, et al. Among authors: poole dj. Cancer Res. 2003 Nov 15;63(22):7942-9. Cancer Res. 2003. PMID: 14633725

8

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.

Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY. Cereda V, et al. Among authors: poole dj. Cancer Immunol Immunother. 2010 Jan;59(1):63-71. doi: 10.1007/s00262-009-0723-6. Epub 2009 Jun 4. Cancer Immunol Immunother. 2010. PMID: 19495750 Free PMC article.

9

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.

Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J. Gulley JL, et al. Among authors: poole dj. Cancer Immunol Immunother. 2010 May;59(5):663-74. doi: 10.1007/s00262-009-0782-8. Epub 2009 Nov 5. Cancer Immunol Immunother. 2010. PMID: 19890632 Free PMC article. Clinical Trial.

10

General keynote: vaccine strategies for the therapy of ovarian cancer.

Hodge JW, Tsang KY, Poole DJ, Schlom J. Hodge JW, et al. Among authors: poole dj. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S97-104; discussion S110-3. doi: 10.1006/gyno.2002.6694. Gynecol Oncol. 2003. PMID: 12586096 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters